The transmembrane receptor-like protein encoded by the proto-oncogene Human Epidermal Growth Factor Receptor 2 (HER2) gene has tyrosine kinase activity, and HER2 is an important prognostic factor for breast cancer. Breast cancer with HER2 gene amplification or protein overexpression has special clinical features and biological behaviors, and the treatment regimen is very different from other types of breast cancer. Therefore, the use of FISH, PCR, and IHC detection methods to evaluate HER2 status on multiple dimensions is of great significance in the accurate typing of breast cancer and the selection of treatment options.
Low testing cost, mature technology, and easy clinical development
Stomach and breast cancer, etc.
If you have any of the following needs, feel free to contact us or email us at inquiry@MEDxTMC.net . We will reply within 24 hours.
1. Customized or bulk orders of IVD/CDx products.
2. Get a quote for IVD/CDx products
3. Become our distributor
4. Get customized pharmaceutical service solutions
5.Learn more about our technology and R&D